“…Furthermore, effective methods of transforming C. utilis have been developed, using electroporation and several bacterial antibiotic resistance markers, such as genes conferring resistance to G418 (APT), hygromycin B (HPT), or cycloheximide (mutated RPL41). 2,3) These techniques have since been used in the heterologous production of, e.g., monellin, -amylase, and carotenoids such as lycopene. [4][5][6][7] Compared with S. cerevisiae, however, the utilization of genetically modified C. utilis has been hampered due to its polyploidy, its imperfect life cycle, and the limited set of selection-marker genes.…”